Sentinel Node Biopsy in Post-neoadjuvant Chemotherapy Breast Cancer Patients Using Pre-chemotherapy Breast Tattooing

Overview

Journal Indian J Surg Oncol

Specialty Oncology

Date 2024 Nov 18

PMID 39555364

Authors

Rexeena Bhargavan

Paul Augustine

Kurian Cherian

Jagathnath K M Krishna

Neelima Radhakrishnan

Affiliations

Soon will be listed here.

Abstract

The role of sentinel lymph node biopsy (SLNB) in locally advanced breast cancer (LABC) post-neoadjuvant chemotherapy (NACT) is debatable. We conducted a novel pilot study in which pre-NACT tattooing of breast lumps in LABC patients resulted in black tattoos being deposited in the axillary node. We hypothesized that this black node was the sentinel node. The identification rate (IR) of the black node in our pilot study was 100%, and the false-negative rate (FNR) was 0%. This study aims to evaluate our hypothesis that the black node is the sentinel node in post-NACT LABC patients after pre-NACT breast tattooing. This is a cross-sectional study of prospectively collected data of women with LABC undergoing surgery after NACT. Patients underwent tattooing of breast primarily using black tattoo ink prior to NACT. Women who progressed on NACT were excluded. All patients underwent axillary dissection. Intraoperatively identified black nodes were sent separately for pathological evaluation. The accuracy of the black nodes was assessed using IR and FNR. Of the 214 patients, a complete clinical response was present in 36%. Black node IR was 88.8% and FNR was 17.4%. In pre-NACT cN0 and cN1 patients, IR was 100% and 96.6%, and FNR was 0% and 4.63%, respectively. SLNB using pre-NACT tattooing in LABC patients has a high IR and FNR. In the subset with low pre-NACT axillary burden (cN0 or cN1), SLNB by pre-NACT breast tattooing has a high IR and low FNR.

References

Giuliano A, Ballman K, McCall L, Beitsch P, Brennan M, Kelemen P . Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017; 318(10):918-926. PMC: 5672806. DOI: 10.1001/jama.2017.11470. View

Caudle A, Yang W, Krishnamurthy S, Mittendorf E, Black D, Gilcrease M . Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol. 2016; 34(10):1072-8. PMC: 4933133. DOI: 10.1200/JCO.2015.64.0094. View

Classe J, Loaec C, Gimbergues P, Alran S, Tunon de Lara C, Dupre P . Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Breast Cancer Res Treat. 2018; 173(2):343-352. DOI: 10.1007/s10549-018-5004-7. View

Jung S, Han J, Park S, Lee E, Kwak J, Kim S . The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center.... Ann Surg Oncol. 2019; 26(8):2409-2416. DOI: 10.1245/s10434-019-07400-0. View

Donker M, van Tienhoven G, Straver M, Meijnen P, van de Velde C, Mansel R . Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014; 15(12):1303-10. PMC: 4291166. DOI: 10.1016/S1470-2045(14)70460-7. View

Dujmovic A, Jurisic N, Mance M, Bulic K, Vrbanovic Mijatovic V, Mijatovic D . Tattoo Pigment within Regional Lymph Nodes Mimicking Cutaneous Melanoma Metastasis. Acta Dermatovenerol Croat. 2020; 28(1):47-48. View

Kluger N, Koljonen V . The surgeon, the tattoo and the black lymph node. J Plast Reconstr Aesthet Surg. 2012; 66(4):561-2. DOI: 10.1016/j.bjps.2012.10.004. View

Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G . Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013; 14(7):609-18. DOI: 10.1016/S1470-2045(13)70166-9. View

Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V . A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003; 349(6):546-53. DOI: 10.1056/NEJMoa012782. View

10.

Manganoni A, Sereni E, Pata G, Ungari M, Pavoni L, Farisoglio C . Pigmentation of axillary sentinel nodes from extensive skin tattoo mimics metastatic melanoma: case report. Int J Dermatol. 2013; 53(6):773-6. DOI: 10.1111/ijd.12417. View

11.

Chirappapha P, Chatmongkonwat T, Lertsithichai P, Pipatsakulroj W, Sritara C, Sukarayothin T . Sentinel lymph node biopsy after neoadjuvant treatment of breast cancer using blue dye, radioisotope, and indocyanine green: Prospective cohort study. Ann Med Surg (Lond). 2020; 59:156-160. PMC: 7548931. DOI: 10.1016/j.amsu.2020.09.030. View

12.

Choy N, Lipson J, Porter C, Ozawa M, Kieryn A, Pal S . Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients. Ann Surg Oncol. 2014; 22(2):377-82. DOI: 10.1245/s10434-014-4034-6. View

13.

Siso C, de Torres J, Esgueva-Colmenarejo A, Espinosa-Bravo M, Rus N, Cordoba O . Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment. Ann Surg Oncol. 2017; 25(3):784-791. DOI: 10.1245/s10434-017-6270-z. View

14.

Tan V, Goh B, Fook-Chong S, Khin L, Wong W, Yong W . The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer--a systematic review and meta-analysis. J Surg Oncol. 2011; 104(1):97-103. DOI: 10.1002/jso.21911. View

15.

Straver M, Loo C, Alderliesten T, Rutgers E, Vrancken Peeters M . Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer. Br J Surg. 2010; 97(8):1226-31. DOI: 10.1002/bjs.7073. View

16.

DiSipio T, Rye S, Newman B, Hayes S . Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013; 14(6):500-15. DOI: 10.1016/S1470-2045(13)70076-7. View

17.

Mango V, Wynn R, Feldman S, Friedlander L, Desperito E, Patel S . Beyond Wires and Seeds: Reflector-guided Breast Lesion Localization and Excision. Radiology. 2017; 284(2):365-371. DOI: 10.1148/radiol.2017161661. View

18.

Boileau J, Poirier B, Basik M, Holloway C, Gaboury L, Sideris L . Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2014; 33(3):258-64. DOI: 10.1200/JCO.2014.55.7827. View

19.

Zatecky J, Kubala O, Coufal O, Kepicova M, Faridova A, Raus K . Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial. Breast Care (Basel). 2021; 16(4):383-388. PMC: 8436608. DOI: 10.1159/000510380. View

20.

Balasubramanian R, Morgan C, Shaari E, Kovacs T, Pinder S, Hamed H . Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy. Eur J Surg Oncol. 2019; 46(6):1028-1033. DOI: 10.1016/j.ejso.2019.12.007. View